WINDTREE THERAPEUTICS INC /DE/ Amortization of Debt Discount (Premium)
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Amortization of Debt Discount (Premium) of $1.29 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2016-03-29
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt discount (premium) for the quarter ending 2014-12-31 was $534.00K, a 130.17% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt discount (premium) for the quarter ending 2014-09-30 was $504.00K, a 303.20% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt discount (premium) for the quarter ending 2014-06-30 was $470.00K, a 298.31% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt discount (premium) for the quarter ending 2014-03-31 was $439.00K, a 670.18% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt discount (premium) for fiscal 2015 was $1.29M, a 33.93% decline from fiscal 2014.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt discount (premium) for fiscal 2014 was $1.95M, a 264.79% increase from fiscal 2013.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt discount (premium) for fiscal 2013 was $534.00K.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt discount (premium) for fiscal 2012 was $0.00.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2015-12-31 | $1.29M 10-K · filed 2016-03-29 | |||
| 2014-12-31 | $534.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $1.04M derived: sum of 2 quarters · filed 2016-03-29 | $1.51M derived: sum of 3 quarters · filed 2016-03-29 | $1.95M 10-K · filed 2016-03-29 |
| 2014-09-30 | $504.00K 10-Q · filed 2014-11-07 | $974.00K derived: sum of 2 quarters · filed 2014-11-07 | $1.41M 10-Q · filed 2014-11-07 | $1.65M derived: sum of 4 quarters · filed 2015-03-16 |
| 2014-06-30 | $470.00K 10-Q · filed 2014-08-07 | $909.00K 10-Q · filed 2014-08-07 | $1.14M derived: sum of 3 quarters · filed 2015-03-16 | $1.27M derived: sum of 4 quarters · filed 2015-03-16 |
| 2014-03-31 | $439.00K 10-Q · filed 2014-05-12 | $671.00K derived: sum of 2 quarters · filed 2015-03-16 | $796.00K derived: sum of 3 quarters · filed 2015-03-16 | $914.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-12-31 | $232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $357.00K derived: sum of 2 quarters · filed 2015-03-16 | $475.00K derived: sum of 3 quarters · filed 2015-03-16 | $534.00K 10-K · filed 2015-03-16 |
| 2013-09-30 | $125.00K 10-Q · filed 2014-11-07 | $243.00K derived: sum of 2 quarters · filed 2014-11-07 | $302.00K 10-Q · filed 2014-11-07 | $300.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $118.00K 10-Q · filed 2014-08-07 | $177.00K 10-Q · filed 2014-08-07 | $175.00K derived: sum of 3 quarters · filed 2015-03-16 | $175.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $57.00K 10-Q · filed 2013-05-07 | $57.00K derived: sum of 2 quarters · filed 2015-03-16 | $57.00K derived: sum of 3 quarters · filed 2015-03-16 | $57.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 |
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $0.00 10-Q · filed 2013-08-08 | $0.00 10-Q · filed 2013-08-08 | ||
| 2011-12-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |